BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 186954)

  • 1. [Excretion of cyclic adenosine monophosphate in breast and lung cancer].
    Bershteĭn LM; Semiglazov VF; Baldina EA
    Vopr Onkol; 1976; 22(8):30-5. PubMed ID: 186954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation].
    Bershteĭn LM; Tsyrlina EV; Semiglazov VF; Valdina EA; L'vovich EG
    Vopr Med Khim; 1979; 25(2):144-8. PubMed ID: 220799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of parathyroid hormone and insulin on extracellular cyclic adenosine-3',5'-monophosphate in patients with benign and malignant breast tumors.
    Berstein LM; Semiglazov VF; Vishnevski AS; Dilman VM
    Neoplasma; 1978; 25(3):329-35. PubMed ID: 210408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclic adenosine monophosphate in the fatty tissue of breast and lung cancer patients].
    Bershteĭn LM; Seleznev IK; Lemekhov VG
    Vopr Med Khim; 1981; 27(5):607-11. PubMed ID: 6274096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary excretion of cAMP in patients with malignant tumours.
    Van der Velden PC; Naafs MA; Fischer HR; Hackeng WH; Koorevaar G; Schopman W; Silberbusch J
    Neth J Med; 1983; 26(1):10-7. PubMed ID: 6300710
    [No Abstract]   [Full Text] [Related]  

  • 6. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.
    Murad F; Pak CY
    N Engl J Med; 1972 Jun; 286(26):1382-7. PubMed ID: 4337769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steroid balance in patients with breast hyperplasia].
    Samundzhan EM; Gorevaia AN; Kartavova NS; Makarchuk NM; Nekrasov PIa
    Vopr Onkol; 1978; 24(8):83-7. PubMed ID: 695432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary estrogen excretion in preneoplastic breast diseases].
    Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
    Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclic adenosine monophosphate content in the lymphocytes of cancer patients].
    Bershteĭn LM; Revskoĭ SIu; Kovaleva IG; Dil'man VM
    Eksp Onkol; 1985; 7(5):53-6. PubMed ID: 2998725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cyclic 3'5'-adenosine monophosphate excretion in parathyroid dysfunction.
    Ullrich IH; Lizarralde G
    Chronobiologia; 1977; 4(3):199-204. PubMed ID: 202439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of cyclic AMP in hyperparathyroidism.
    Wålinder O; Ljunghall S; Wibell L
    Scand J Urol Nephrol; 1978; 12(1):67-71. PubMed ID: 204993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of cAMP and cGMP in bronchogenic carcinoma complicated by hypertrophic osteoarthropathy.
    Francini G; Nami R; Grossi A; Gennari C
    Panminerva Med; 1983; 25(1):19-21. PubMed ID: 6306543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adaptational and thyroid homeostasis and the state of fat and carbohydrate metabolism in lung cancer].
    Bershteĭn LM; Valdina EA; Barchuk AS; Fadeev NP; L'vovich EG
    Vopr Onkol; 1978; 24(2):48-52. PubMed ID: 636385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
    Tagliaferri P; Katsaros D; Clair T; Ally S; Tortora G; Neckers L; Rubalcava B; Parandoosh Z; Chang YA; Revankar GR
    Cancer Res; 1988 Mar; 48(6):1642-50. PubMed ID: 2830966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphometric and biochemical peculiarities of fatty tissue in patients with cancer of the breast and lung].
    Bershteĭn LM; Barchuk AS; Lemekhov VG; Seleznev IK; Semiglazov VF
    Vopr Onkol; 1983; 29(4):45-51. PubMed ID: 6305031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) in asthmatic and normal children.
    König P; Carpenter M; White AA
    Eur J Respir Dis; 1980 Aug; 61(4):218-26. PubMed ID: 6258958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer].
    Bershteĭn LM; Bobrov IuF; Ostroumova MN; Kovalenko IG; Lemekhov VG
    Vopr Onkol; 1985; 31(1):44-51. PubMed ID: 3883650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.